Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

BACKGROUND: Esophageal cancers accounted for nearly 16,000 deaths in 2016. The number of patients with esophageal cancers increases every year. Neoadjuvant chemoradiotherapy (nCRT) prior to esophagectomy is a standard treatment for esophageal cancers. The patients who have no residual tumor (patholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor Ripley, R., Surman, Deborah R., Diggs, Laurence P., Trepel, Jane B., Lee, Min-Jung, Ryan, Jeremy, Davis, Jeremy L., Steinberg, Seth M., Hernandez, Jonathan M., Hoang, Choung, Kenney, Cara M., Bond, Colleen D., Kunst, Tricia F., Letai, Anthony, Schrump, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013848/
https://www.ncbi.nlm.nih.gov/pubmed/29933761
http://dx.doi.org/10.1186/s12876-018-0823-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013848/
https://www.ncbi.nlm.nih.gov/pubmed/29933761
http://dx.doi.org/10.1186/s12876-018-0823-x

Ejemplares similares